PROVIDER PROFILE · NPI 1801098033

Dev BoodoosinghMD

Pulmonary DiseasePonce, PRI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$6K

Peer benchmark

Total Medicare services vs. 104 Pulmonary Disease providers in PR — below median (cohort median 125).

PRESCRIBING · PART D · 2024

Total Rx claims

3,960

Beneficiaries

—

Total drug cost

$2.6M

Distinct drugs

Brand share

64.1%

Top prescribed drugs

Fluticasone/Umeclidin/Vilanter576 claims

Montelukast Sodium424 claims

Fluticasone Propionate289 claims

Budesonide/Formoterol Fumarate275 claims

Levocetirizine Dihydrochloride264 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$1K

Consulting Fee$200

Education$23

REFERRAL NETWORK

Where Dev Boodoosingh's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Pedro Whatts Anesthesiology · Ponce, PR	23	43
GOMEZ DE NERY, CRISTINA	17	24
Cesar Cruz-Garcia Cardiology · Ponce, PR	17	43
Oscar Quintero Serrano Cardiology · Ponce, PR	12	31
Rafael Espinet Perez Internal Medicine · Ponce, PR	12	46
Alejandra Santiago Endocrinology · Ponce, PR	12	23
Domingo Chardon Pulmonary Disease · Ponce, PR	11	21

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history